TwinBeech Capital’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,122
Closed -$430K 530
2024
Q1
$430K Buy
+14,122
New +$473K 0.01% 466
2023
Q4
Sell
-28,877
Closed -$1.26M 647
2023
Q3
$1.26M Buy
28,877
+6,511
+29% +$318K 0.02% 465
2023
Q2
$1.1M Buy
+22,366
New +$1.03M 0.02% 449
2022
Q3
Sell
-14,007
Closed -$572K 619
2022
Q2
$572K Buy
14,007
+2,030
+17% +$96.2K 0.03% 409
2022
Q1
$787K Buy
+11,977
New +$776K 0.03% 353
2021
Q4
Sell
-48,936
Closed -$3.4M 560
2021
Q3
$3.4M Buy
48,936
+35,690
+269% +$2.75M 0.24% 125
2021
Q2
$1.05M Buy
+13,246
New +$963K 0.13% 207
2021
Q1
Sell
-4,189
Closed -$233K 450
2020
Q4
$233K Buy
+4,189
New +$181K 0.04% 389
2020
Q3
Sell
-10,812
Closed -$486K 420
2020
Q2
$486K Buy
+10,812
New +$471K 0.11% 236

Other funds holding ATRC

TwinBeech Capital's ATRC Position: Q2 2024 in Review

TwinBeech Capital sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 14,122 shares — an estimated $430K sold.

TwinBeech Capital first reported a position in ATRC in Q2 2020 and held it in 9 quarters. The position peaked at $3.4M in Q3 2021. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.

  • TwinBeech Capital reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
  • TwinBeech Capital sold 14,122 AtriCure shares in Q2 2024, an estimated $430K.
  • TwinBeech Capital first reported a position in AtriCure in Q2 2020 and held it in 9 quarters.
  • TwinBeech Capital's AtriCure position peaked at $3.4M in Q3 2021.
  • 197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.

Based on TwinBeech Capital's 13F filing for Q2 2024, filed 14 Aug 2024.